L.B. Bohle Showcases High-Efficiency BRC 100 Dry Granulator? for First Time in the U.S. at INTERPHEX 2013

Register for the BRC 100 webinar on April 11, and then see it at booth 2641

WARMINSTER, Pa. (March 25, 2013) — L.B. Bohle, a leading manufacturer of high-efficiency pharmaceutical processing and handling equipment, will launch its BRC 100 dry granulator to U.S. audiences at INTERPHEX 2013. The company will display the BRC 100 at booth 2641, April 23-25 at the Javits Center, New York.

Dry granulation is now often the process of choice for large-volume or moisture-sensitive pharmaceutical products. The BRC 100 enables high-production capacity with minimal material loss. This is achieved through fast and precise control of the compaction force with a new electromechanical spindle drive for the two rollers.

The BRC 100 achieves ribbon granulation with the Bohle Turbo Sieve (BTS 200). The conical sieve allows gentle particle size reduction at low sieve speeds, which is also applicable at high material throughputs. A variety of different sieve types make the BRC 100 flexible for different product and ribbon properties. Additionally, constant ribbon properties are assured over a wide production range (up to 400 kg/hr, product dependent).

Prior to INTERPHEX on April 11, Dejan Djuric, Ph.D., L.B. Bohle’s manager of scientific operations, will present a one-hour webinar on dry granulation and the BRC 100. Titled “Equipment Considerations for Continuous Dry Granulation,” the webinar will cover the theory of dry granulation, review roller compactor designs, and feature a case study on the BRC 100’s processing capabilities. To register for the webinar, visit http://www.interphex.com/en/Education/Webinar-Series.

At INTERPHEX, L.B. Bohle’s pharmaceutical processing experts will also be available to discuss continuous improvement for granulation and tablet coating. Continuous improvements to these processing technologies help to significantly reduce production costs, minimize intermediate storage, and avoid costly in-process controls. L.B. Bohle’s specialists will discuss how improvements in equipment and processes will move pharmaceutical manufacturers closer to achieving these goals.

To schedule an interview with one of L.B. Bohle’s pharmaceutical processing experts at INTERPHEX, contact Brian Courtney at [email protected] or (610) 269-2100, ext. 249.

About L.B. Bohle LLC

L.B. Bohle LLC, the U.S. subsidiary of L.B. Bohle Maschinen & Verfahren GmbH, provides high-efficiency processing technologies benefitting the pharmaceutical and nutraceutical markets, including tablet coating, milling, granulating, blending, material handling and weighing equipment. With 30 years experience and more than 35 patents worldwide, L.B. Bohle continues to develop innovative technologies which meet the challenges of the pharmaceutical industry, making the company one of the world’s leading manufacturers of pharmaceutical processing equipment. For more information, visit www.lbbohle.com or call (215) 957-1240.

Media Contact:
Brian Courtney
Schubert Communications Inc.
610-269-2100, ext. 249
[email protected]

More News

  • Researchers Propose New Regulations for Food Packaging Chemicals

    Scientists have proposed a new way to prioritize regulatory review of the more than 15,000 chemicals used in food packaging and other food contact materials, most of which currently lack the safety data needed to protect consumers. read more
  • Brain Activity Mirrors the Shape of Each Breath

    Each individual breath—not just breathing rate—is closely linked to the pattern of electrical activity in brain regions tied to cognition, emotion and memory, according to a new study that could help explain how breathing disorders turn deadly. read more
  • Body's Organs Age in Distinct, Synchronized Waves

    The human body doesn't age at a single, steady pace. Instead, each organ follows its own timeline, and organs that age quickly tend to have "aging partners" that speed up in sync, according to a new study that mapped structural aging across 40 types of tissue. read more